The Drug Abuse Research Center brings together four laboratory groups employing different approaches to the neurobiological bases for actions of drugs of abuse. Multidisciplinary approaches in the laboratories include biochemistry, molecular biology, neuroanatomy and neurophysiology with substantial technical and conceptual coordination and collaboration between groups. The common thematic focus, as in past periods of support, is The Dynamics of Signaling by Molecular Messengers Relevant to Actions of Drugs of Abuse. Snyder will explore three areas of signal transduction with a special focus on neurotoxicity (1) nitric oxide synthase associated proteins (2) heme oxygenase products: CO and bilirubin (3) glyceraldehydes-3-phosphate dehydrogenase and cell death. The Dawsons will identify and characterize genes dependent on signaling by calcium and NMDA receptor transmission. Worley will deal with the function and regulation of immediate early genes that are dynamically regulated by cocaine with a special emphasis on Rheb, a novel member of the Ras signaling pathway. Baraban will focus on two aspects of intraneuronal signaling linked to neuronal plasticity and drug abuse. One is Tech, a guanine nucleotide exchange factor for Rho family members, that is selectively expressed in neurons. The other is Translin, a component of RNA binding complexes that have been implicated in dentritic RNA processing.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA000266-34
Application #
6898943
Study Section
Special Emphasis Panel (ZDA1-RXL-E (15))
Program Officer
Pollock, Jonathan D
Project Start
1975-06-20
Project End
2007-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
34
Fiscal Year
2005
Total Cost
$2,737,132
Indirect Cost
Name
Johns Hopkins University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Hinkle, Jared T; Perepezko, Kate; Bakker, Catherine C et al. (2018) Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis. Int J Geriatr Psychiatry 33:e131-e139
Hinkle, Jared T; Perepezko, Kate; Mills, Kelly A et al. (2018) Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease. Parkinsonism Relat Disord 55:8-14
Piard, Juliette; Umanah, George K Essien; Harms, Frederike L et al. (2018) A homozygous ATAD1 mutation impairs postsynaptic AMPA receptor trafficking and causes a lethal encephalopathy. Brain :
Hinkle, Jared T; Perepezko, Kate; Rosenthal, Liana S et al. (2018) Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias. Parkinsonism Relat Disord 47:50-56
Berger, Nathan A; Besson, Valerie C; Boulares, A Hamid et al. (2018) Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases. Br J Pharmacol 175:192-222
Chern, Yijuang; Chien, Ting; Fu, Xiuping et al. (2018) Trax: A versatile signaling protein plays key roles in synaptic plasticity and DNA repair. Neurobiol Learn Mem :
Paul, Bindu D; Snyder, Solomon H (2018) Gasotransmitter hydrogen sulfide signaling in neuronal health and disease. Biochem Pharmacol 149:101-109
Vasavda, Chirag; Zaccor, Nicholas W; Scherer, Paul C et al. (2017) Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding. J Vis Exp :
Park, Alan Jung; Havekes, Robbert; Fu, Xiuping et al. (2017) Learning induces the translin/trax RNase complex to express activin receptors for persistent memory. Elife 6:
Fu, Chenglai; Xu, Jing; Cheng, Weiwei et al. (2017) Neuronal migration is mediated by inositol hexakisphosphate kinase 1 via ?-actinin and focal adhesion kinase. Proc Natl Acad Sci U S A 114:2036-2041

Showing the most recent 10 out of 108 publications